GranuFlo Dialysis Product May Hurt St. Louis Residents

On October 3, 2012, in Defective Drugs, by K. Lindsay Rakers

Fresenius is currently being investigated by the FDA for failing to warn patients of potential dangers with its product, GranuFlo.  A well-respected blood dialysis physician here in St. Louis, Missouri at Washington University, Dr. Coyne, has reported that 30% of his dialysis patients have a high level of bicarbone in their system.  This is scary stuff.  Read further information at the Legal Examiner.

If you or a loved one has been injured by GranuFlo dialysis products, please contact Lindsay Rakers.

Tagged with:
 

One Response to GranuFlo Dialysis Product May Hurt St. Louis Residents

  1. John Clavenna says:

    Early this year my wife died of a heart attack after two months of dialysis.
    She was barely sixty years old and had never had a stroke or any unmanaged
    heart problems. Was it GranuFlo? Would appreciate your thoughts.

Leave a Reply

Your email address will not be published. Required fields are marked *



Proud Supporters Of

picture picture picture picture picture picture picture picturepicture